Euroapi SAS
Research Euroapi SAS (EAPI) on Bullrun: market cap EUR 124.70M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerEAPI
- ExchangePA
- CountryFrance
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 124.70M
- Financial periodFY2025
- RevenueEUR 852.60M
- Revenue growth-7.2%
- Net income-EUR 211.20M
- Free cash flowEUR 50.00M
- Gross margin17.0%
Valuation Snapshot
latest market cap is EUR 124.70M.
About Euroapi SAS
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that use solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins;
Frequently asked questions
What is Euroapi SAS's market cap?
Euroapi SAS's market capitalization is EUR 124.70M.
What does Euroapi SAS do?
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally.